You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

liso-cel

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

Not yet recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • +6 more
  • Bridging radiation therapy
  • +2 more
  • (no location specified)
Jan 4, 2023

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +2 more
  • Biopsy
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Anakinra
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +3 more
  • lisocabtagene maraleucel
  • Gilbert, Arizona
  • +40 more
Apr 22, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022

Diffuse Large B Cell Lymphoma Trial in Rouen (CAR-T cells monitoring)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • CAR-T cells monitoring
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

CAR-T Retreatment Trial in Shanghai (axi-cel)

Recruiting
  • CAR-T Retreatment
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Mar 23, 2023

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Sickle Cell Disease Trial (Exa-cel)

Not yet recruiting
  • Sickle Cell Disease
  • Exa-cel
  • (no location specified)
Jul 14, 2023

Multiple Myeloma Trial (Cilta-cel OOS Therapy)

Available
  • Multiple Myeloma
  • Cilta-cel OOS Therapy
  • (no location specified)
Aug 15, 2022

Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Large B-cell Lymphoma
  • Axicabtagene Ciloleucel
  • Palo Alto, California
    Stanford University
Mar 20, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Transformed Lymphoma
  • Handgrip strength test
  • +9 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)

Recruiting
  • Systemic Lupus Erythematosus
  • Relma-cel
  • Shanghai, China
    Relma-cel Medical
Mar 12, 2023

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023